| 1 |
Expression and antigenicity of recombinant human respiratory syncytial virus glycoproteins having different affinity tags
Lee HS, Kim AR, Kim K, Lee WJ, Kim SS, Kim YJ
Protein Expression and Purification, 132, 1, 2017 |
| 2 |
Purification of human respiratory syncytial virus fusion glycoprotein
Zheng YP, Tang YN, Fu YH, He JS, Wang XB, Hong T
Protein Expression and Purification, 81(1), 115, 2012 |
| 3 |
A prime-boost vaccination strategy using attenuated Salmonella typhimurium and a replication-deficient recombinant adenovirus vector elicits protective immunity against human respiratory syncytial virus
Fu YH, He JS, Wang XB, Zheng XX, Wu Q, Xie C, Zhang M, Wei W, Tang Q, Song JD, Qu JG, Hong T
Biochemical and Biophysical Research Communications, 395(1), 87, 2010 |
| 4 |
Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice
Fu YH, He JS, Zheng XX, Wu Q, Zhang M, Wang XB, Wang Y, Xie C, Tang Q, Wei W, Wang M, Song JD, Qu JG, Zhang Y, Wang X, Hong T
Biochemical and Biophysical Research Communications, 381(4), 528, 2009 |
| 5 |
Production of polyclonal antibodies against the human respiratory syncytial virus nucleoprotein and phosphoprotein expressed in Escherichia coli
Simabuco FM, Carromeu C, Farinha-Arcieri LE, Tamura RE, Ventura AM
Protein Expression and Purification, 53(1), 209, 2007 |
| 6 |
Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion
Wang EX, Sun X, Qian Y, Zhao LQ, Tien P, Gao GF
Biochemical and Biophysical Research Communications, 302(3), 469, 2003 |
